(Reuters) – Pfizer Inc and its German partner BioNTech SE will seek emergency use authorization for a second booster shot of their COVID-19 vaccine for people aged 65 and older, the Washington Post reported on Tuesday, citing people familiar with the matter.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)
